LGALS1 and prostate carcinoma: The high expression of Galectin-1 is associated with the migration and invasion of gastric cancer cells and poor prognosis of patients with prostate cancer (Shih et al., 2018) and hepatocellular carcinoma (Tsai et al., 2022).